BMJ  2005;330:205-206 (29 January), doi:10.1136/bmj.330.7485.205

Editorial

Reduction in mortality from breast cancer

Screening and increased use of adjuvants are responsible—adjuvants more so

The first 150 words of the full text of this article appear below.

The survival of women who will be diagnosed with breast cancer in the United Kingdom and Europe in 2005 is significantly better than that for their counterparts diagnosed in the 1970s and '80s, although five year survival remains lower in Europe than in the United States (79% v 89%).¹ What is known about the reasons for these differences, and what could increase survival still more?

Any improvement in survival is unlikely to be attributable to a change in the biological behaviour of breast cancer. It must reflect improvement, therefore, in diagnosing and managing breast cancer, leading to fewer distant relapses and deaths. This could be a consequence of early detection through screening or improved systemic treatment with adjuvants after surgery to eliminate micrometastases and prevent recurrence. However, screening amounts to secondary prevention rather than primary prevention. Delay in diagnosing symptomatic breast cancer is associated with inferior survival,² but as . . . [Full text of this article]

Academic Department of Oncology, Royal Free and University College Hospitals, London NW3 2QG (alison.jones@royalfree.nhs.uk)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Reduction in mortality from breast cancer: Reasons for improved survival are more complex than suggested

Graeme W Morgan
BMJ 2005 330: 1025. [Extract] [Full Text]

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

Gianni Bonadonna, Angela Moliterni, Milvia Zambetti, Maria Grazia Daidone, Silvana Pilotti, Luca Gianni, and Pinuccia Valagussa
BMJ 2005 330: 217. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., Kroll, T., Jorke, C., Hammer, U., Altendorf-Hofmann, A., Rabenstein, C., Pachmann, U., Runnebaum, I., Hoffken, K. (2008). Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse. JCO 26: 1208-1215 [Abstract] [Full text]  
• Fisch, T., Pury, P., Probst, N., Bordoni, A., Bouchardy, C., Frick, H., Jundt, G., De Weck, D., Perret, E., Lutz, J.-M. (2005). Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol 16: 1882-1888 [Abstract] [Full text]  
• Morgan, G. W (2005). Reduction in mortality from breast cancer: Reasons for improved survival are more complex than suggested. BMJ 330: 1025-1025 [Full text]  

Rapid Responses:

Read all Rapid Responses

Reduction in breast cancer mortality

Graeme W Morgan
bmj.com, 30 Jan 2005 [Full text]

Relative risk

Alan C Gibbs
bmj.com, 11 Feb 2005 [Full text]